Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Pharmacology Research & Perspectives|October 29, 2021
Donepezil improves vascular function in a mouse model of Alzheimer's diseaseCarolina Pellegrini, Vanessa D'Antongiovanni, Matteo Fornai, et al.Human Brain Mapping|January 24, 2014
Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairmentCarlo Tessa, Claudio Lucetti, Marco Giannelli, et al.Toxins|October 23, 2019
Plasma Levels of Oxidative Stress Markers, before and after <i>BoNT/A</i> Treatment, in Chronic MigraineElisa Dini, Sonia Mazzucchi, Ciro De Luca, et al.Journal of Clinical and Experimental Neuropsychology|December 11, 2012
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's diseaseMichele Poletti, Daniela Frosini, Cristina Pagni, et al.American Journal of Alzheimer'S Disease and Other Dementias|September 22, 2017
Oxidative Stress Assessment in Alzheimer's Disease: A Clinic Setting StudyAndrea Vergallo, Linda Giampietri, Filippo Baldacci, et al.Clinical Neuropharmacology|November 11, 2014
Dopamine agonist modifies cortical activity in Parkinson disease: a functional neuroimaging studyClaudio Lucetti, Stefano Diciotti, Filippo Baldacci, et al.Expert Review of Molecular Diagnostics|June 13, 2026
Fluid biomarkers in Cerebral amyloid angiopathy: current limitations and future directionsMarta Del Chicca, Gaia Mignani, Fabio Iannaccone, et al.Oxidative Medicine and Cellular Longevity|January 25, 2021
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms?Rebecca Piccarducci, Simona Daniele, Beatrice Polini, et al.Journal of Clinical Psychopharmacology|July 17, 2013
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugsMichele Poletti, Chiara Logi, Claudio Lucetti, et al.Diagnostics (Basel, Switzerland)|April 23, 2022
Fluid Biomarkers in Alzheimer's Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored TreatmentsLinda Giampietri, Elisabetta Belli, Maria Francesca Beatino, et al.Pageof 9